Health

YS Biopharma Granted Patent in the U.S. for Immunotherapy Targeting Chronic Hepatitis B Virus Infection

GAITHERSBURG, Md., Sept. 15, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious dise...

2023-09-15 20:30 2328

Prenetics Announces Second Quarter 2023 Financial Results

HONG KONG, Sept. 15, 2023 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics-driven health sciences company, today announced financial results for the second quarter endedJune 30, 2023, along with recent business updates. Second Quarter 2023...

2023-09-15 19:10 5898

MGI Introduces New Chapter in Smart Laboratory Management with Official Opening of αLab in HKSTP

HONG KONG, Sept. 15, 2023 /PRNewswire/ -- MGI, a company committed to building core tools and technology to lead life science, today announced the official opening of αLab in the Hong Kong Science & Technology Parks ("HKSTP"), the city's largest R&D base and one of the most important incubators. ...

2023-09-15 18:35 2449

Neoss® Group has launched a new wireless intraoral scanner, NeoScan™ 2000

ZURICH, Sept. 15, 2023 /PRNewswire/ -- Neoss Group, a leading innovator in dental implant solutions, is proud to announce the fast and easy-to-use wireless intraoral scanner, NeoScan™ 2000. This follows the success of last year's launch of the NeoScan™ 1000.

2023-09-15 16:00 1978

Green Leadership Award Presented to Chugai Pharma Taiwan at the Asia Responsible Enterprise Awards 2023

SINGAPORE, Sept. 14, 2023 /PRNewswire/ -- The Asia Responsible Enterprise Awards (AREA) 2023 is pleased to honor 30 outstanding business leaders and enterprises for championing sustainable and responsible business practices. Presented by leading regional NGO Enterprise Asia, the AREA is the mo...

2023-09-15 11:37 1850

MGI Partners with National Cancer Centre Singapore to Undergo Comprehensive Genomic Profiling of Asian-Prevalent Cancers

SINGAPORE, Sept. 15, 2023 /PRNewswire/ -- MGI Tech Singapore Pte, Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, recently entered a research partnership with National Cancer Centre Singapore ("NCCS") to facilitate comprehensive, multi-dimensional gen...

2023-09-15 11:00 2622

MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study

GENEVA, Sept. 15, 2023 /PRNewswire/ -- MedAlliance has announced enrollment of over 1,660 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now half way towards a planned 3,326 patients. SELUTION DeNovo compares the treatment strategy using a novel sirolimu...

2023-09-15 08:00 2075

Variants in the genome interact with each other and with the environment to affect risk of cardiovascular disease

REYKJAVIK, Iceland, Sept. 14, 2023 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from the Icelandic healthcare system and TheCopenhagen University, publish a study today in the journal Cell titled "Complex effects of sequence variants on lipid level...

2023-09-14 23:00 2303

Foundry Mixer Healthcare, Indonesian Minister of Health Budi G. Sadikin: "Together We Leapfrog Indonesia's Healthcare Transformation"

Indonesian Minister of Health, Budi Gunadi Sadikin, emphasized that investing in the Health Technology and Biotechnology sector serves not only business prospects but also strengthens Indonesia's health resilience and adds value to healthcare. JAKARTA, Indonesia, Sept. 14, 2023 /PRNewswire/ -- F...

2023-09-14 17:47 1683

Break the cycle of dehydration and skin sensitivity with the NEW Cetaphil® Optimal Hydration Skin Replenishing Water Gel

The NEW Cetaphil Skin Replenishing Water Gel is clinically proven to provide 72-hour hydration with its slow-release technology containing Hyaluronic Acid and Polyglutamic Acid KUALA LUMPUR, Malaysia, Sept. 14, 2023 /PRNewswire/ -- Cetaphil®, the #1 dermatological skincare brand inMalaysia intro...

2023-09-14 17:17 1899

Neoss® Group launches NeoTell™ a new device to measure implant stability.

ZÜRICH, Sept. 14, 2023 /PRNewswire/ -- Earlier this year, Neoss Group, a pioneer in dental implant solutions, announced a partnership with Osstell AB, a global leader in implant stability measurement and osseointegration progress monitoring. Today, we proudly introduce the first fruit of this col...

2023-09-14 16:00 1643

Two Affiliated Hospitals Unveiled Simultaneously, Neusoft Education Exerts Efforts In a New Ecosystem Of Healthcare Technology Education

HONG KONG, Sept. 14, 2023 /PRNewswire/ -- On the morning of September 14, the unveiling ceremony of Dalian Neusoft University of Information's affiliated Cardiovascular Hospital and affiliated Stomatological Hospital was held at the phase II square of the provincial-level university science and t...

2023-09-14 13:53 4850

Innovative Collaboration: Buzzreach and Oncoshot Spearhead Clinical Trial Advancements in Japan

SINGAPORE, Sept. 14, 2023 /PRNewswire/ -- Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration to accelerate clinical trials inJapan. The former specialises in clinical trial site recruitment and retention and project managemen...

2023-09-14 10:00 2546

MGI and Bio-Medical Science Sign MOU to Deliver Cutting-Edge Sequencing Platforms and Reagents to South Korea

CHEONAN, South Korea, 14 September 2023 /PRNewswire/ -- MGI, a company committed to building core tools and technology to lead life science, today announced MOU with Bio-Medical Science Co., Ltd. ("BMS") to expand genomics solutions inSouth Korea by leveraging MGI's cutting-edge technology. The M...

2023-09-14 09:00 1849

Avasa raises $1.55M in oversubscribed funding round with innovative implantable devices

MIAMI and AUCKLAND, New Zealand, Sept. 14, 2023 /PRNewswire/ -- Avasa, a medical device pioneer advancing surgical techniques for improved patient outcomes, announces the successful completion of its recent funding, raising an impressive$1.55 million in capital investment. The influx of new inves...

2023-09-14 04:50 1981

AWAK TECHNOLOGIES RAISES US$20+ MILLION, READYING ITS WEARABLE DIALYSIS DEVICE FOR US-BASED PIVOTAL TRIAL

* AWAK closes one of the largest MedTech fundraise in 2023 in Southeast Asia * The Series B round was co-led by new investor Lion X Ventures and long-term investor Vickers Venture Partners, along with other new and existing investors * AWAK's ultra-portable peritoneal dialysis system enables ...

2023-09-13 21:27 2496

Exelixis and Insilico Medicine Enter into Exclusive Global License Agreement for ISM3091, a Potentially Best-in-Class USP1 Inhibitor

— ISM3091 is a highly selective, orally bioavailable small molecule inhibitor of USP1  identified through Insilico Medicine's artificial intelligence (AI) platform, with potent activity in BRCA-mutated tumor models — — In May 2023, the U.S. Food and Drug Administration (FDA) cleared Insilico's I...

2023-09-13 20:29 1958

Global Times: Witness to history: Chinese people in Morocco share life-and-death earthquake experiences, rush to assist locals to get through disaster

BEIJING, Sept. 13, 2023 /PRNewswire/ -- At 1.28 am, obstetrician Zhang Qian finally heard the loud cry of a baby. It was a healthy baby girl. Zhang breathed a sigh of relief performing after a nerve-racking hour-long C-section on a Moroccan patient. While in surgery at a Moroccan hospital, Zhang ...

2023-09-13 19:48 1619

91% of doctors in Southeast Asia participate in digital learning despite societal return to in-person interactions - Docquity

* Docquity survey shows that doctor attendance at digital learning events is higher than in-person events (at 3.9 versus 3.0 times per month) * While two learning cohorts have emerged - digital dominant learners and in-person dominant learners, both groups participate in digital learning yet ...

2023-09-13 10:55 749

Menarini Asia-Pacific Enters into an Exclusive Licensing Agreement with Astellas to Commercialize Smyraf® in Taiwan and select South-East Asian markets

SINGAPORE, Sept. 13, 2023 /PRNewswire/ -- Menarini Asia-Pacific has entered into a long-term exclusive licensing partnership with Astellas Pharma Inc. (Astellas) for the development, manufacturing and commercialization of the orally administered Janus kinase (JAK) inhibitor Smyraf® 50 mg and 100 ...

2023-09-13 10:30 2605
1 ... 125126127128129130131 ... 582